Funding for this research was provided by:
Received: 5 February 2018
Accepted: 3 April 2018
First Online: 7 April 2018
Ethics approval and consent to participate
: The Committee on Human Subjects at Joslin Diabetes Center approved the study design (Protocol CHS# 2014–40). The trail was registered at ExternalRef removed (NCT02520050). All subjects have signed a consent form to participate of the study.
: OH is on advisory board of Astra Zeneca, Inc. and is consultant to Merck Inc. He is shareholder of Healthimation, LLC. He receives research grants from Novo-Nordisk, Inc., Intracia, Inc., Abbott, Inc. and the National Dairy Council. JM receives research grants the National Dairy Council. AM, VS, B-NM-Y, WM, PC and DP report no conflicts of interest related to this work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.